Error: Could not add to watchlist. X
+ Watchlist

Hard to Treat Diseases Inc/FL

HTDS:US
OTC US
0.00
USD
0.00
0.00%
As of 8:10 PM EDT 7/27/2017
Volume
100,000
Previous Close
0.00
52Wk Range
0.00 - 0.00
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
100,000
Previous Close
0.00
52Wk Range
0.00 - 0.00
YTD Return
900.00%
Current P/E Ratio (TTM)
-
Earnings per Share (-) (TTM)
-
Market Cap (k USD)
548.234
Shares Outstanding (b)
5.482
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Hard to Treat Diseases Incorporated holds the international marketing rights, except South Korea, to Tubercin, an immunostimulant. The Company's product is a nasal spray developed for combating cancer and rheumatoid arthritis, targeted to the holistic product market. Hard to Treat Diseases is also seeking to market its chemical process for the disposal and recycling of Styrofoam.
Address
1885 Southwest 4th Avenue
Building E-3
Delray Beach, FL 33444
United States
Phone
1-561-272-6900
Show More